May 28, 1999
Emory and Pharmaceutical Company Settle Patent Dispute Over a Promising Drug
Emory University and the Glaxo Wellcome pharmaceutical company have settled a dispute over rights to patents and data on a drug that shows promise in treating H.I.V. and hepatitis B.
University officials would not disclose the exact terms of the settlement. But they said the agreement would insure that a young biotechnology company with ties to Emory, Triangle Pharmaceuticals, had all the intellectual-property
This is an article for subscribers only. You may access this article by purchasing a:
Digital or Print Subscription
Web Pass
Already have an account? Log In Now.
-
Peer Review

-
Academic Assets

-
Teaching


